CompletedNot Applicable

Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism

China60 participantsStarted 2020-07-30

Plain-language summary

This study is designed to observe the effect of 5:2 intermittent calorie restriction (fasting 2 days each week) on liver fat content in MASLD patients with abnormal blood glucose.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Impaired glucose regulation: fasting blood glucose ≥ 100 mg/dL, postprandial blood glucose ≥ 140 mg/dL or HbA1c ≥ 5.7%
✓. Diabetes mellitus: diabetic symptoms + plasma glucose concentration ≥ 200 mg/dL at any time or fasting plasma glucose concentration ≥ 100 mg/dL or OGTT 2 h plasma glucose concentration ≥ 200 mg/dL

What they're measuring

Change of Liver Fat Content in %

Timeframe: From baseline to week 12

Trial details

NCT IDNCT04283942

SponsorShanghai Zhongshan Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-25

Results submitted2023-12-03

View on ClinicalTrials.gov More Fatty Liver Disease trials